Cilo Cybin is a pioneering company based in South Africa. Established in 2018, it specializes in the production of cannabis GMP distillates, oils, and vapes aimed at the medical cannabis industry. Their slogan, "South Africa’s leading cannabis GMP manufacturer of distillates, oils and vapes for the medical cannabis industry," showcases their commitment to quality and innovation.
The company's approach is centered around a fusion of Biohacking, Biotech, and Pharmaceutical methodologies. This generates a personalized and comprehensive solution that provides customers with unprecedented insights into their health, performance, and longevity.
It’s crucial to understand Biotech & Pharmaceutical. While both produce medicines, biotechnology companies derive theirs from living organisms, whereas pharmaceutical companies generally use a chemical basis. Moreover, Biohacking is defined as the continual pursuit of improved health, performance, and longevity through the integration of various technologies, applications, devices, and supplementation.
As of now, Cilo Cybin does not have publicly disclosed recent investment details or the involved investors. With a focus on Manufacturing and Pharmaceutical industries, Cilo Cybin's innovative approach and commitment to quality position it as a key player in the evolving medical cannabis landscape in South Africa.